{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 53688
    }
  },
  "results": [
    {
      "safetyreportversion": "2",
      "safetyreportid": "10004003",
      "primarysourcecountry": "US",
      "occurcountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20141002",
      "reporttype": "1",
      "serious": "2",
      "receivedateformat": "102",
      "receivedate": "20140312",
      "receiptdateformat": "102",
      "receiptdate": "20140324",
      "fulfillexpeditecriteria": "2",
      "companynumb": "US-VERTEX PHARMACEUTICALS INC-2014-001226",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "VERTEX",
        "duplicatenumb": "US-VERTEX PHARMACEUTICALS INC-2014-001226"
      },
      "primarysource": {
        "reportercountry": "US",
        "qualification": "5"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "48",
        "patientonsetageunit": "801",
        "patientweight": "100",
        "patientsex": "1",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Injection site rash",
            "reactionoutcome": "3"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "White blood cell count decreased",
            "reactionoutcome": "3"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Rash erythematous",
            "reactionoutcome": "3"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "INCIVEK",
            "drugbatchnumb": "348409",
            "drugauthorizationnumb": "201917",
            "drugstructuredosagenumb": "3",
            "drugstructuredosageunit": "032",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "12",
            "drugintervaldosagedefinition": "805",
            "drugdosagetext": "3 DF, BID",
            "drugdosageform": "TABLET",
            "drugadministrationroute": "048",
            "drugindication": "HEPATITIS C",
            "drugstartdateformat": "102",
            "drugstartdate": "20140130",
            "drugenddateformat": "102",
            "drugenddate": "20140220",
            "drugrecurreadministration": "3"
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "INCIVEK",
            "drugauthorizationnumb": "201917",
            "drugstructuredosagenumb": "3",
            "drugstructuredosageunit": "032",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "12",
            "drugintervaldosagedefinition": "805",
            "drugdosagetext": "3 DF, BID",
            "drugdosageform": "TABLET",
            "drugadministrationroute": "048",
            "drugstartdateformat": "102",
            "drugstartdate": "20140303",
            "drugrecurreadministration": "3"
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "RIBAVIRIN",
            "drugdosagetext": "2 TABS IN AM, 3 TABS IN PM",
            "drugadministrationroute": "048",
            "drugindication": "HEPATITIS C",
            "drugstartdateformat": "102",
            "drugstartdate": "20140130",
            "drugenddateformat": "102",
            "drugenddate": "20140220",
            "drugrecurreadministration": "3",
            "openfda": {
              "application_number": [
                "NDA018859",
                "ANDA207366",
                "ANDA079111",
                "ANDA079117"
              ],
              "brand_name": [
                "VIRAZOLE",
                "RIBAVIRIN"
              ],
              "generic_name": [
                "RIBAVIRIN"
              ],
              "manufacturer_name": [
                "Bausch Health US, LLC",
                "Navinta LLC",
                "Aurobindo Pharma Limited",
                "Oceanside Pharmaceuticals",
                "Cameron Pharmaceuticals",
                "Zydus Pharmaceuticals USA Inc."
              ],
              "product_ndc": [
                "0187-0007",
                "68475-003",
                "65862-207",
                "68682-019",
                "65862-290",
                "42494-423",
                "68382-395"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "RESPIRATORY (INHALATION)",
                "ORAL"
              ],
              "substance_name": [
                "RIBAVIRIN"
              ],
              "rxcui": [
                "207406",
                "312818",
                "248109",
                "312817"
              ],
              "spl_id": [
                "a2282c58-67c0-48ac-ae4f-f05e98d6f3c0",
                "76819c30-2ece-43cf-a329-6bc3720ac870",
                "683ccd3f-445b-4488-b14c-8d5810d8633a",
                "6b3c6edc-c735-46e0-9b31-fac85dda0992",
                "229cfa05-05e1-493e-87ba-0511fed12e66",
                "4f6faa39-5ffa-18d6-e063-6394a90a8e07",
                "5b244567-d037-4fbd-9e2b-ed394e1c07b4"
              ],
              "spl_set_id": [
                "adf16e64-345f-469a-b987-3fbdd17e0ac2",
                "39723ea2-780c-4266-954a-869723b144c4",
                "eee304d0-c2ea-44f4-97d9-92a414d31b6c",
                "d74aa4f3-0b7d-480d-b5bf-41ddf808b260",
                "35f99f76-f2ef-4a81-91ff-285419664be3",
                "7ea8dafa-d3d8-493e-a0db-e783d92fb13f",
                "2c3a64d5-fde2-437b-bafc-e76dd187d85a"
              ],
              "package_ndc": [
                "0187-0007-14",
                "0187-0007-01",
                "68475-003-04",
                "65862-207-68",
                "65862-207-05",
                "68682-019-06",
                "68682-019-01",
                "65862-290-42",
                "65862-290-56",
                "65862-290-70",
                "65862-290-84",
                "65862-290-18",
                "65862-290-05",
                "42494-423-01",
                "68382-395-04"
              ],
              "nui": [
                "N0000175459",
                "N0000175466"
              ],
              "pharm_class_epc": [
                "Nucleoside Analog Antiviral [EPC]"
              ],
              "unii": [
                "49717AWG6K"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "RIBAVIRIN",
            "drugdosagetext": "2 TABS IN AM, 3 TABS IN PM",
            "drugadministrationroute": "048",
            "drugstartdateformat": "102",
            "drugstartdate": "20140303",
            "drugrecurreadministration": "3",
            "openfda": {
              "application_number": [
                "NDA018859",
                "ANDA207366",
                "ANDA079111",
                "ANDA079117"
              ],
              "brand_name": [
                "VIRAZOLE",
                "RIBAVIRIN"
              ],
              "generic_name": [
                "RIBAVIRIN"
              ],
              "manufacturer_name": [
                "Bausch Health US, LLC",
                "Navinta LLC",
                "Aurobindo Pharma Limited",
                "Oceanside Pharmaceuticals",
                "Cameron Pharmaceuticals",
                "Zydus Pharmaceuticals USA Inc."
              ],
              "product_ndc": [
                "0187-0007",
                "68475-003",
                "65862-207",
                "68682-019",
                "65862-290",
                "42494-423",
                "68382-395"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "RESPIRATORY (INHALATION)",
                "ORAL"
              ],
              "substance_name": [
                "RIBAVIRIN"
              ],
              "rxcui": [
                "207406",
                "312818",
                "248109",
                "312817"
              ],
              "spl_id": [
                "a2282c58-67c0-48ac-ae4f-f05e98d6f3c0",
                "76819c30-2ece-43cf-a329-6bc3720ac870",
                "683ccd3f-445b-4488-b14c-8d5810d8633a",
                "6b3c6edc-c735-46e0-9b31-fac85dda0992",
                "229cfa05-05e1-493e-87ba-0511fed12e66",
                "4f6faa39-5ffa-18d6-e063-6394a90a8e07",
                "5b244567-d037-4fbd-9e2b-ed394e1c07b4"
              ],
              "spl_set_id": [
                "adf16e64-345f-469a-b987-3fbdd17e0ac2",
                "39723ea2-780c-4266-954a-869723b144c4",
                "eee304d0-c2ea-44f4-97d9-92a414d31b6c",
                "d74aa4f3-0b7d-480d-b5bf-41ddf808b260",
                "35f99f76-f2ef-4a81-91ff-285419664be3",
                "7ea8dafa-d3d8-493e-a0db-e783d92fb13f",
                "2c3a64d5-fde2-437b-bafc-e76dd187d85a"
              ],
              "package_ndc": [
                "0187-0007-14",
                "0187-0007-01",
                "68475-003-04",
                "65862-207-68",
                "65862-207-05",
                "68682-019-06",
                "68682-019-01",
                "65862-290-42",
                "65862-290-56",
                "65862-290-70",
                "65862-290-84",
                "65862-290-18",
                "65862-290-05",
                "42494-423-01",
                "68382-395-04"
              ],
              "nui": [
                "N0000175459",
                "N0000175466"
              ],
              "pharm_class_epc": [
                "Nucleoside Analog Antiviral [EPC]"
              ],
              "unii": [
                "49717AWG6K"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "PEGASYS",
            "drugstructuredosagenumb": "180",
            "drugstructuredosageunit": "004",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "803",
            "drugdosagetext": "180 ?G, QW",
            "drugadministrationroute": "058",
            "drugindication": "HEPATITIS C",
            "drugstartdateformat": "102",
            "drugstartdate": "20140130",
            "drugenddateformat": "102",
            "drugenddate": "20140220",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "openfda": {
              "application_number": [
                "BLA103964"
              ],
              "brand_name": [
                "PEGASYS"
              ],
              "generic_name": [
                "PEGINTERFERON ALFA-2A"
              ],
              "manufacturer_name": [
                "pharmaand GmbH"
              ],
              "product_ndc": [
                "82154-0449",
                "82154-0451"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "SUBCUTANEOUS"
              ],
              "substance_name": [
                "PEGINTERFERON ALFA-2A"
              ],
              "rxcui": [
                "351270",
                "352297",
                "731326",
                "731328"
              ],
              "spl_id": [
                "3c18e4a2-193f-ef4e-e063-6394a90a56b2"
              ],
              "spl_set_id": [
                "d9290e5b-6d40-2318-e053-2995a90a9916"
              ],
              "package_ndc": [
                "82154-0449-1",
                "82154-0451-4"
              ],
              "nui": [
                "N0000175521",
                "M0025711"
              ],
              "pharm_class_epc": [
                "Interferon alpha [EPC]"
              ],
              "pharm_class_cs": [
                "Interferon-alpha [CS]"
              ],
              "unii": [
                "Q46947FE7K"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "PEGASYS",
            "drugstructuredosagenumb": "180",
            "drugstructuredosageunit": "004",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "803",
            "drugdosagetext": "180 ?G, QW",
            "drugadministrationroute": "058",
            "drugstartdateformat": "102",
            "drugstartdate": "20140303",
            "drugenddateformat": "102",
            "drugenddate": "20140307",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "openfda": {
              "application_number": [
                "BLA103964"
              ],
              "brand_name": [
                "PEGASYS"
              ],
              "generic_name": [
                "PEGINTERFERON ALFA-2A"
              ],
              "manufacturer_name": [
                "pharmaand GmbH"
              ],
              "product_ndc": [
                "82154-0449",
                "82154-0451"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "SUBCUTANEOUS"
              ],
              "substance_name": [
                "PEGINTERFERON ALFA-2A"
              ],
              "rxcui": [
                "351270",
                "352297",
                "731326",
                "731328"
              ],
              "spl_id": [
                "3c18e4a2-193f-ef4e-e063-6394a90a56b2"
              ],
              "spl_set_id": [
                "d9290e5b-6d40-2318-e053-2995a90a9916"
              ],
              "package_ndc": [
                "82154-0449-1",
                "82154-0451-4"
              ],
              "nui": [
                "N0000175521",
                "M0025711"
              ],
              "pharm_class_epc": [
                "Interferon alpha [EPC]"
              ],
              "pharm_class_cs": [
                "Interferon-alpha [CS]"
              ],
              "unii": [
                "Q46947FE7K"
              ]
            }
          }
        ]
      }
    }
  ]
}